Our top pick for
IHS Holding Ltd is a telecom services business based in the US. IHS Holding shares (IHS) are listed on the NYSE and all prices are listed in US Dollars. IHS Holding employs 2,292 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$10.35|
|52-week range||$9.21 - $18.48|
|50-day moving average||$11.01|
|200-day moving average||$12.42|
|Wall St. target price||$20.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.07|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-29)||0.49%|
|1 month (2022-06-07)||-14.60%|
|3 months (2022-04-07)||-9.69%|
|6 months (2022-01-03)||N/A|
|1 year (2021-07-03)||N/A|
|2 years (2020-07-03)||N/A|
|3 years (2019-07-03)||N/A|
|5 years (2017-07-03)||N/A|
Valuing IHS Holding stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IHS Holding's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IHS Holding's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 151x. In other words, IHS Holding shares trade at around 151x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, IHS Holding's P/E ratio is best considered in relation to those of others within the telecom services industry or those of similar companies.
IHS Holding's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $732.8 million.
The EBITDA is a measure of a IHS Holding's overall financial performance and is widely used to measure a its profitability.
To put IHS Holding's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$1.7 billion|
|Operating margin TTM||24.91%|
|Gross profit TTM||$738 million|
|Return on assets TTM||5.13%|
|Return on equity TTM||1.3%|
|Market capitalisation||$3.5 billion|
TTM: trailing 12 months
We're not expecting IHS Holding to pay a dividend over the next 12 months.
You may also wish to consider:
IHS Holding Limited, together with its subsidiaries, owns, operates, and develops shared telecommunications infrastructure in Africa, Latin America, Europe, and the Middle East. It offers colocation and lease agreement, build-to-suit, fiber connectivity, and rural telephony solutions. The company serves mobile network operators, internet service providers, broadcasters, security functions, and private corporations. IHS Holding Limited was founded in 2001 and is based in London, the United Kingdom. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.